Discover Opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis
This contract includes 1 purchase order from Sep 9, 2024 to Sep 9, 2024
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| NIH NCI | Leidos Biomedical Research, Inc. | Sep 9, 2024 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
NIAID-VRC-RESEARCH, DEVELOPMENT, AND PRODUCTION TO SUPPORT CLINICAL TESTING OF VACCINES AGAINST SEASONAL OR PANDEMIC INFLUENZA VIRUSES
Effective Date
Sep 9, 2022
Expires
Effective: Sep 9, 2022
Expires:
NIAID-VRC-RESEARCH, DEVELOPMENT, AND PRODUCTION TO SUPPORT CLINICAL TESTING OF VACCINES AGAINST SEASONAL OR PANDEMIC INFLUENZA VIRUSES
ActiveNIAID-DMID MONKEYPOX VACCINE CLINICAL TRIAL - JYNNEOS DOSE SPARING TRIAL
Effective Date
Sep 16, 2022
Expires
Effective: Sep 16, 2022
Expires:
NIAID-DMID MONKEYPOX VACCINE CLINICAL TRIAL - JYNNEOS DOSE SPARING TRIAL
ActiveADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)
Effective Date
Feb 16, 2021
Expires
Effective: Feb 16, 2021
Expires:
ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)
ActiveNIAID-DMID-ANTIVIRAL PROGRAM FOR PANDEMICS EARLY PHASE CLINICAL TRIAL(S)
Effective Date
Sep 16, 2022
Expires
Effective: Sep 16, 2022
Expires:
NIAID-DMID-ANTIVIRAL PROGRAM FOR PANDEMICS EARLY PHASE CLINICAL TRIAL(S)
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis